Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 25,000 shares at $31.19 ($785K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Scheduled sale ($785k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.19 | 17,291 | $539K | 68.7% |
| 2 | $31.86 | 7,709 | $246K | 31.3% |
| Total | $31.40 avg | 25,000 | $785K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |